153 related articles for article (PubMed ID: 23552384)
1. Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP).
Abraham RM; Karakousis G; Acs G; Ziober AF; Cerroni L; Mihm MC; Elder DE; Xu X
Am J Surg Pathol; 2013 May; 37(5):669-75. PubMed ID: 23552384
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic invasion predicts sentinel lymph node metastasis and adverse outcome in primary cutaneous melanoma.
Moy AP; Mochel MC; Muzikansky A; Duncan LM; Kraft S
J Cutan Pathol; 2017 Sep; 44(9):734-739. PubMed ID: 28555886
[TBL] [Abstract][Full Text] [Related]
3. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.
Bayram A; Ozturk Sari S; Ozluk Y; Tas F; Buyukbabani N
J Cutan Pathol; 2021 Apr; 48(4):472-478. PubMed ID: 32935876
[TBL] [Abstract][Full Text] [Related]
4. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
5. Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.
Vermariën-Wang J; Doeleman T; van Doorn R; Mooyaart AL; Blokx WAM; Schrader AMR
J Am Acad Dermatol; 2023 Mar; 88(3):602-608. PubMed ID: 36403750
[TBL] [Abstract][Full Text] [Related]
6. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
Pusiol T; Morichetti D; Piscioli F; Zorzi MG
Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
[TBL] [Abstract][Full Text] [Related]
7. Optimizing Detection of Lymphatic Invasion in Primary Cutaneous Melanoma With the Use of D2-40 and a Paired Melanocytic Marker.
Straker RJ; Taylor LA; Neuwirth MG; Sinnamon AJ; Shannon AB; Abbott J; Miura JT; Chu EY; Xu X; Karakousis GC
Am J Dermatopathol; 2022 Jan; 44(1):21-27. PubMed ID: 34231497
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.
Xu X; Chen L; Guerry D; Dawson PR; Hwang WT; VanBelle P; Elder DE; Zhang PJ; Ming ME; Schuchter L; Gimotty PA
Clin Cancer Res; 2012 Jan; 18(1):229-37. PubMed ID: 22096024
[TBL] [Abstract][Full Text] [Related]
9. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.
Cerroni L; Barnhill R; Elder D; Gottlieb G; Heenan P; Kutzner H; LeBoit PE; Mihm M; Rosai J; Kerl H
Am J Surg Pathol; 2010 Mar; 34(3):314-26. PubMed ID: 20118771
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.
Massi D; De Nisi MC; Franchi A; Mourmouras V; Baroni G; Panelos J; Santucci M; Miracco C
Mod Pathol; 2009 Jan; 22(1):21-30. PubMed ID: 18660796
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features, Dermoscopic Patterns, and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP).
Pusiol T; Piscioli F; Speziali L; Zorzi MG; Morichetti D; Roncati L
Acta Dermatovenerol Croat; 2015; 23(3):185-94. PubMed ID: 26476902
[TBL] [Abstract][Full Text] [Related]
12. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus.
Zembowicz A; Carney JA; Mihm MC
Am J Surg Pathol; 2004 Jan; 28(1):31-40. PubMed ID: 14707861
[TBL] [Abstract][Full Text] [Related]
13. Are locoregional cutaneous metastases in melanoma predictable?
Borgstein PJ; Meijer S; van Diest PJ
Ann Surg Oncol; 1999; 6(3):315-21. PubMed ID: 10340893
[TBL] [Abstract][Full Text] [Related]
14. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
15. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008.
Berk DR; LaBuz E; Dadras SS; Johnson DL; Swetter SM
Pediatr Dermatol; 2010; 27(3):244-54. PubMed ID: 20403119
[TBL] [Abstract][Full Text] [Related]
16. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
18. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
Urso C
J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
[TBL] [Abstract][Full Text] [Related]
19. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic tumour with unknown malignant potential--a Danish study of 67 patients.
Kaltoft B; Hainau B; Lock-Andersen J
Melanoma Res; 2015 Feb; 25(1):64-7. PubMed ID: 25396682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
